it probably has a lot to do with the news that ABT is laying off 700 manufacturing jobs associated with the stent they were supplying to BSC....with the expiration of that contract a LOT....a WHOLE LOT of stent sales will revert back, in full, to BSC....without having to fork over a dime to ABT for them.
this is BIG ....very big.... millions in additional profit... monthly!!
I've heard the royalty number was at 40%. Put that straight to the bottom line and the future qtrs look good. Especially when coupled with the fact that Promus Element law suit by JNJ has been cleared.